micro-community-banner
  • Saved
Extrapulmonary pneumocystosis in an antiretroviral therapy-naïve, HIV-positive patient - PubMed

Extrapulmonary pneumocystosis in an antiretroviral therapy-naïve, HIV-positive patient - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35398297/

Pneumocystis jirovecii is a common opportunistic fungal pathogen that commonly affects immunocompromised individuals and can cause P. jirovecii pneumonia. Extrapulmonary P. jirovecii infections are extremely rare. Herein, we present a...



Conclusion: After starting ART, the patient's clinical condition improved and the abscesses gradually reduced. TMP-SMX is commonly used to treat EPC; however, there is no standard method of treatment. ART may become the key to EPC treatment in individuals with HIV infection.

  • Saved
COVID-19 vaccination and HIV-1 acquisition

COVID-19 vaccination and HIV-1 acquisition

Source : https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00332-4/fulltext

Susan P Buchbinder and colleagues1 express concern that COVID-19 vaccines utilising replication-defective adenovirus vectors of human serotype 5 (HAdV-5) might increase the risk of HIV-1 acquisition. Such concern has prompted...



Conclusion: Due vigilance and monitoring of adverse events, including HIV-1 infection rates, are absolutely crucial in the pandemic response and the roll-out of vaccines, but still, we would urge global health authorities to license and distribute any efficacious and safe vaccines that are available especially while access to COVID-19 vaccines...